It only becomes competition AFTER GTCB gets factor VIIa into clinical trials. We will see how many screw ups and delays GTCB has in store before actually getting into trials. Your post refers to yet another company that can get significant cash for producing their drugs, but somehow GTCB can't seem to be able to figure out how to do it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.